Ergomed is a global provider of services to the biotech and pharmaceutical industries. The company is a leading independent, specialist provider of pharmacovigilance services and oncology/rare disease-focused Contract Research Organisation (CRO) services. Ergomed operates in structurally growing markets, benefitting from tailwinds of increasing complexity, regulatory requirements and outsourcing rates.